Month: March 2023

NEW YORK, March 29, 2023 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Stronghold”, the “Company”, or “we”) today announced financial and operational results for the fourth quarter and full year 2022 and provided an operational update. Recent Operational and Financial HighlightsFourth quarter 2022 revenue of $23.4 million, net loss of $47.4 million, and non-GAAP adjusted EBITDA of $5.2 million Current liquidity of approximately $8.8 million, comprising $7.7 million in cash plus 39 Bitcoin as of March 28, 2023 Current principal amount of debt outstanding of approximately $59.8 million and net debt of approximately $51.0 million (calculated as principal amount of debt outstanding less cash and Bitcoin) as of March 28, 2023 Entered into Amended Credit Agreement with WhiteHawk Finance LLC (“WhiteHawk”) and/or...

TORONTO, March 29, 2023 (GLOBE NEWSWIRE) —  (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF (the “Fund”) announces results of operations for the period ended December 31, 2022. Decrease in net assets attributable to holders of units amounted to $6.62 million or $1.49 per unit. As at December 31, 2022, net assets attributable to holders of units were $56.64 million or $7.40 per unit. Cash distributions to unitholders totaling $2.87 million or $0.58 per unit were paid during the period. The Fund is a mutual fund investment trust that seeks to provide unitholders with long-term capital appreciation through exposure to a portfolio consisting principally of common shares of Bank of Montreal, The Bank of Nova Scotia, Canadian Imperial Bank of Commerce, National Bank of Canada, Royal Bank of Canada and The Toronto-Dominion Bank...

Revenue of $66 Million for Full Year 2022 Meets Full Year Outlook Company Achieves Positive Gross Margins in Q4 BEDFORD, Mass. , March 29, 2023 (GLOBE NEWSWIRE) — Berkshire Grey Inc. (Nasdaq: BGRY) (the “Company”), a leader in AI-enabled robotic solutions that automate supply chain processes, today announced results for its fourth quarter and year ended December 31, 2022. The Company:Executed 71 installations of Berkshire Grey’s advanced robotics solutions during 2022. Entered 2023 with backlog of approximately $100 million. Increased total orders since inception to $265 million. Achieved positive gross margin in the fourth quarter of 2022.“We had another strong quarter in terms of execution, and we continue to make significant progress improving our financial performance,” said Tom Wagner, Chief Executive Officer of the Company....

Completed enrollment of the Phase 2 PEAK Trial of AVTX-002 in non-eosinophilic asthma (NEA); topline data expected in the second quarter of 2023 Disclosed cash of approximately $13 million as of December 31, 2022, non-inclusive of the February 2023 public offering Increased cash position with closing of public offering of common stock and warrants for gross proceeds of $15 million on February 7, 2023WAYNE, Pa. and ROCKVILLE, Md., March 29, 2023 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and year-end financial results for 2022. “We made significant strategic and operational progress over the past year, by executing our goals of streamlining the pipeline to the most promising assets/trials, implementing corresponding infrastructure cost reductions, executing operationally and extending...

Expects to submit BLA for EB-101 to FDA in late-2Q/early-3Q 2023 based on positive Phase 3 VIITAL™ study results announced in 4Q 2022 Advancing AAV-based gene therapy candidates toward IND studies in Stargardt Disease, X-linked Retinoschisis, and Autosomal Dominant Optic Atrophy Strengthened senior management team with executive appointments and promotions NEW YORK and CLEVELAND, March 29, 2023 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the full year of 2022 and provided an update on progress toward achieving key corporate objectives. The Company will host a conference call and webcast today, March 29, 2023, at 8:30 a.m. ET, to discuss its financial results and business update. “Since announcing positive topline results for the Phase 3 VIITAL study late last year, we...